Logo-jrip
Submitted: 17 Jul 2020
Accepted: 02 Oct 2020
ePublished: 14 Oct 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2021;10(2): e11.
doi: 10.34172/jrip.2021.11

Scopus ID: 85103110243
  Abstract View: 1969
  PDF Download: 1160

Original

Serum uric acid and renal survival prognosis in primary glomerulonephritis patients in a retrospective single-center cohort

Natalia Stepanova 1* ORCID logo, Lyudmila Snisar 1 ORCID logo, Larysa Lebid 1 ORCID logo, Svitlana Savchenko 1, Valentyn Nepomnyashchii 1, Mykola Kolesnyk 1 ORCID logo

1 State Institution “Institute of Nephrology of the National Academy of Medical Sciences”, Kyiv, Ukraine
*Corresponding Author: Email: nmstep88@gmail.com

Abstract

Introduction: The role of serum uric acid (SUA) concentration in primary glomerulonephritis (PGN) aggravation is currently under active discussion.

Objectives: This study primarily aimed to analyze the association between SUA concentration and renal survival prognosis in PGN patients and secondarily to determine whether hyperuricemia is an independent risk factor for reduced glomerular filtration rate (GFR) in the presence of nephrotic syndrome.

Patients and Methods: We performed a retrospective observational single-center study involving 344 patients with biopsy-proved or clinically diagnosed PGN with the mean follow-up period of 5.3 [3.8-6.2] years. The rate of annual decline in estimated GFR (eGFR) was used to assess chronic kidney disease progression. Primary outcome measures were eGFR decline or transfer to renal replacement therapy (RRT) during the 5-year follow-up period.

Results: There were 78/344 (22.7%) patients who eventually progressed to eGFR <15 mL/min/1.73 m2 or started RRT. In multivariate logistic regression analysis eGFR at diagnosis, proteinuria and hyperuricemia were associated with increased renal risk in PGN patients during the 5-year follow-up period. However, a less significant effect of SUA on rapid eGFR decline was found in the patients with nephrotic-range proteinuria compared with the patients with mild proteinuria.

Conclusion: Our study revealed that a higher level of SUA was significantly associated with a greater annual decline in GFR and, consequently, a worse 5-year renal survival prognosis in PGN patients. The effect of hyperuricemia on the risk of rapid CKD progression was greater in PGN patients with mild proteinuria compared with the patients with nephrotic-range proteinuria.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1970

Your browser does not support the canvas element.


PDF Download: 1160

Your browser does not support the canvas element.